BioCopy AG: Accelerating drug development

BioCopy develops AI and automation-based platforms for accelerated drug development, particularly for biotherapeutics in oncology.

Averbis GmbH: Turning data into decisions

Averbis GmbH specialises in AI-supported analysis of unstructured health data. With the help of natural language processing (NLP) and machine learning, clinical texts, findings and documentation are converted into structured, interoperable information.

Alithea Biotechnology GmbH: AI meets immunotherapy

Alithea Biotechnology develops data-driven solutions for modern immunotherapies and combines immunopeptidomics, mass spectrometry and AI-based bioinformatics for the precise identification of therapy-relevant target structures.

MPS GmbH: Digitalised chemotherapy planning

With solutions such as ChemoCompile, MPS develops digital systems for the planning and quality assurance of chemotherapy processes. The software supports medical facilities in therapy planning, resource management and process control.